Our adaptive immune cells have been perfected over 500 million years and are the ideal therapeutic.
Combining AI with high throughput assays to accelerate and revolutionize discovery, Omniscope is decoding our immune system to enable next therapies.
Leverage unparalleled depth and quality of T cell sequencing to train generative AI models and decipher the adaptive immune code.
Coupled with in vitro validation, OS Intercept prioritizes and refines cellular therapeutic candidates through an iterative design-build-test-learn cycle.
Deep T cell repertoire sequencing with OS-T, paired with scalable in vitro models to enable deep reinforcement learning.
Generative AI platform to design novel cellular therapeutics.
Automated target confirmation to validate AI generated designs.
Map complete T cell response:
Up to 1 million T cells per clinical sample
Browsable immune portal:
Identify biomarkers with intuitive data analysis.
